Cellectar Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.04

+0.22 (+7.80%)

As of Feb 8, 2:28 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +1,257.9% upside

Low Target $32.58

Average Target $41.28

High Target $58.47

Current Price $3.04

Current
$3.04

Target
$41.28

$32.58 $41.28 avg $58.47

Scenario Analysis

Bear Case

$32.58

971.7%

Low target

Base Case

$41.28

+1,257.9%

Avg target

Bull Case

$58.47

+1,823.4%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$41.37

-92.7% from high

52-Week Low

$35.04

+-91.3% from low

Target vs 52W High

$41.28

-0.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%